http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101292707-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
filingDate 2005-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101292707-B1
titleOfInvention Inhibitors of Dipeptidylpeptidase IV
abstract The present invention relates to post-proline degrading enzyme inhibitors such as inhibitors of dipeptidyl peptidase IV; Pharmaceutical compositions thereof; And methods of using such inhibitors. In particular, the inhibitors of the present invention have been improved over prior art inhibitors in that they select a special class of side chains at the P1 and / or P2 positions of the inhibitor containing carboxylic acid residues. Such compounds of the present invention may have a good therapeutic index due in part to improved specificity and / or reduced toxicity to the target protease.
priorityDate 2004-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466150522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466067581

Total number of triples: 31.